Who owns Intellia Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of NTLA from SEC Form 13F filings across 329 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 329 institutions disclosed 143.9M shares of Intellia Therapeutics, Inc. worth $2.43B — about 107.8% of shares outstanding; the largest disclosed holder is ARK Investment Management LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
329
13F holders
$2.43B
value, 2026 filers
107.8%
of shares outstanding (143.9M sh)
58
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of NTLA's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | ARK Investment Management LLC | 16.9M | $285.5M | 1.9% | 12.6% | +16.3% |
| 2 | BlackRock, Inc. | 15.4M | $260.7M | 0.0% | 11.5% | +26.8% |
| 3 | STATE STREET CORP | 9.2M | $156.3M | 0.0% | 6.9% | +33.4% |
| 4 | VANGUARD PORTFOLIO MANAGEMENT LLC | 7.3M | $124.1M | 0.0% | 5.5% | +17.8% |
| 5 | D. E. Shaw & Co., Inc. | 6.4M | $109.0M | 0.1% | 4.8% | +12.5% |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 6.0M | $102.0M | 0.0% | 4.5% | +18.6% |
| 7 | TWO SIGMA INVESTMENTS, LP | 5.2M | $88.6M | 0.1% | 3.9% | +11.3% |
| 8 | FMR LLC | 4.8M | $80.8M | 0.0% | 3.6% | +130.9% |
| 9 | RA CAPITAL MANAGEMENT, L.P.NEW | 4.5M | $76.6M | 0.7% | 3.4% | new |
| 10 | REGENERON PHARMACEUTICALS, INC. | 3.7M | $62.7M | 35.4% | 2.8% | 0.0% |
| 11 | GEODE CAPITAL MANAGEMENT, LLC | 3.6M | $61.4M | 0.0% | 2.7% | +27.3% |
| 12 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 3.3M | $55.5M | 0.0% | 2.5% | +134.8% |
| 13 | Sumitomo Mitsui Trust Group, Inc. | 2.9M | $49.0M | 0.0% | 2.2% | +46.9% |
| 14 | Amova Asset Management Americas, Inc. | 2.9M | $49.0M | 0.6% | 2.2% | +46.9% |
| 15 | DIMENSIONAL FUND ADVISORS LP | 2.6M | $44.0M | 0.0% | 2% | +12.3% |
| 16 | GOLDMAN SACHS GROUP INC | 2.3M | $38.3M | 0.0% | 1.7% | +39.1% |
| 17 | UBS Group AG | 2.2M | $36.4M | 0.0% | 1.6% | -20.0% |
| 18 | VOLORIDGE INVESTMENT MANAGEMENT, LLC | 2.1M | $35.0M | 0.1% | 1.5% | +28.2% |
| 19 | Contrarius Group Holdings Ltd | 2.0M | $33.1M | 1.5% | 1.5% | +2.3% |
| 20 | JUPITER ASSET MANAGEMENT LTD | 1.8M | $31.3M | 0.2% | 1.4% | +3.8% |
| 21 | MORGAN STANLEY | 1.7M | $29.3M | 0.0% | 1.3% | -16.8% |
| 22 | ARMISTICE CAPITAL, LLC | 1.5M | $25.4M | 0.3% | 1.1% | +346.4% |
| 23 | RENAISSANCE TECHNOLOGIES LLCNEW | 1.4M | $23.7M | 0.0% | 1% | new |
| 24 | NORTHERN TRUST CORP | 1.3M | $21.5M | 0.0% | 1% | +31.7% |
| 25 | HRT FINANCIAL LP | 1.2M | $21.0M | 0.0% | 0.9% | +147.5% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.